Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome

References

• Merson MH, Piot P. Global perspectives on human immunodeficiency virus infection and acquired immunodeficiency syndrome. In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds), Elsevier, Inc., PA, USA, 1465–1475 (2005).
   Google Scholar
• Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infection in HIV-infected individuals receiving antiretroviral. Lancet Infect. Dis.5, 361–373 (2005).
   PubMed Web of Science ®Google Scholar
• Kumarasamy N, Solomon S, Sreekanth K et al. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in Southern India. Clin. Infect. Dis.41, 1525–1528 (2005).
   PubMed Web of Science ®Google Scholar
• Wester C, Bussmann H, Avalos A et al. Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned. Clin. Infect. Dis.40, 1041–1044 (2005).
   PubMed Web of Science ®Google Scholar
• Akileswaran C, Lurie M, Flanigan T, Mayer K. Lessons learned from use of highly active antiretroviral therapy in Africa. Clin. Infect. Dis.41, 376–385 (2005).
   PubMed Web of Science ®Google Scholar
• Carpenter C. Universal access to antiretroviral therapy: when, not if. Clin. Infect. Dis.42, 260–261 (2006).
   PubMed Web of Science ®Google Scholar
• Kumarasamy N, Flanigan TP, Mahajan AP, Carpenter CCJ, Mayer KH, Solomon S. Monitoring HIV treatment in the developing world. Lancet Infect. Dis.2, 656–657 (2002).
   PubMed Web of Science ®Google Scholar
• Markiwitz N, Hansen HI, Hopewell PC et al. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann. Intern. Med.126, 123–132 (1997).
   PubMed Web of Science ®Google Scholar
• Michailidis C, Pozniak AL, Mandalia S, Basnayake S, Nelson MR, Gazzard BG. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir. Ther.10(3), 417–422 (2005).
   PubMed Web of Science ®Google Scholar
• Gallant JE, DeJesus E, Arribas JR et al. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N. Engl. J. Med.35, 251–260 (2006).
   Google Scholar
• French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS18, 1615–1627 (2004).
   PubMed Web of Science ®Google Scholar
• Bourgarit A, Carcelain G, Martinez V et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS20, F1–F7 (2006).
   PubMed Web of Science ®Google Scholar
• Shelburne SA III, Hamill RJ, Rodriguez-Barradas MC et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore)81, 213–227 (2002).
   PubMed Web of Science ®Google Scholar
• Burman W. Issues in the management of HIV-related tuberculosis. Clin. Chest Med.26, 283–294 (2005).
   PubMed Web of Science ®Google Scholar
• French MA, Lenzo N, John M et al. Immune restoration disease after the treatment of immunodeficient HIV-infection patients with highly active antiretroviral therapy. HIV Med.1, 107–115 (2000).
   PubMedGoogle Scholar
• Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am. J. Respir. Crit. Care Med.158, 157–161 (1998).
   PubMed Web of Science ®Google Scholar
• Wendel KA, Alwood KS, Gachuhi R et al. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest120, 193–197 (2001).
   PubMed Web of Science ®Google Scholar
• Schelburne SA, Visnegarwala F, Darcourt J et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS19, 399–406 (2005).
   PubMed Web of Science ®Google Scholar
• Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J. Infect. Dis.190, 1670–1676 (2004).
   PubMed Web of Science ®Google Scholar
• Posada-Vergara M, Lindoso J, Toezano J, Pereiar-Chioccola VL, Silva MV, Goto H. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J. Infect. Dis.192, 1819–1822 (2005).
   PubMed Web of Science ®Google Scholar
• Puthanakit T, Oberdorfer P, Punjaisee S, Wannarit P, Sirisanthana T, Sirisanthana V. Immune reconstitution syndrome due to bacillus Calmette-Guerin after initiation of antiretroviral therapy in children with HIV infection. Clin. Infect. Dis.41, 1049–1052 (2005).
   PubMed Web of Science ®Google Scholar
• Navas E, Martin-Davila P, Moreno L et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch. Intern. Med.162, 97–99 (2002).
   PubMed Web of Science ®Google Scholar
• Phillips P, Bonner S, Gataric N et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin. Infect. Dis.41, 1483–1497 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng VC, Yuen K, Chan W, Wong S, Ma E, Chan R. Immunorestitution disease involving the innate and adaptive response. Clin. Infect. Dis.30, 882–892 (2000).
   PubMed Web of Science ®Google Scholar
• Cooney E. Clinical indicators of immune restoration following highly active antiretroviral therapy. Clin. Infect. Dis.34, 224–233 (2002).
   PubMed Web of Science ®Google Scholar
• De Jong BC, Israelski DM, Corbett EL, Small PM. Clinical management of tuberculosis in the context of HIV infection. Ann. Rev. Med.55, 283–301 (2004).
   PubMed Web of Science ®Google Scholar
• McComsey GA, Whalen CC, Mawhorter SD et al. Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS15, 321–327 (2001).
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Ferrand SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology25, 53–68 (2000).
   PubMed Web of Science ®Google Scholar
• Piketty C, Jayle, D, Leplege A et al. Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease. Clin. Endocrinol. (Oxf).55, 325–330 (2001).
   PubMed Web of Science ®Google Scholar
• Wallis RS, Kalayjian R, Jacobson JM et al. A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3). J. Acquir. Immune Defic. Syndr.32, 281–286 (2003).
   PubMed Web of Science ®Google Scholar
• DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann. Intern. Med.133, 447–454 (2000).
   PubMed Web of Science ®Google Scholar
• Phillips P, Kwiatkowski MB, Copland M et al. Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.20, 122–128 (1999).
   PubMedGoogle Scholar
• Aberg JA, Chin-Hong PV, McCutchan A et al. Localized osteomyelitis due to Mycobacterium avium complex in patients with human immunodeficiency virus receiving highly active antiretroviral therapy. Clin. Infect. Dis.23, E8–E13 (2002).
   Google Scholar
• Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically divers HIV type 1-infected cohort. Clin. Infect. Dis.42, 418–427 (2006).
   PubMed Web of Science ®Google Scholar
• Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children. Pediatr. Infect. Dis.25, 53–58 (2006).
   Google Scholar
• Furrer H, Malinverni R. Systemic inflammatory reaction after starting highly active antirevriral therapy in AIDS patients treated for extrapulmonary tuberculosis. Am. J. Med.106, 371–372 (1999).
   PubMed Web of Science ®Google Scholar
• Buckinghan SJ, Haddow LJ, Shaw PJ, Miller RF. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacteria infections starting highly active anti-retroviral therapy. Clin. Radiol.59, 505–513 (2004).
   PubMed Web of Science ®Google Scholar
• Breton G, Adle-Biassette H, Therby A et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS20, 119–132 (2006).
   PubMed Web of Science ®Google Scholar
• Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Francoise D for the French cryptococcosis study group. Incidence and risk of immune reconstitution inflammatory syndrome complication HIV-associated cryptococcosis in France. AIDS19, 1043–1049 (2005).
   PubMed Web of Science ®Google Scholar
• Shelburne S, Darcourt J, White CA et al. The role of immune reconstitution imflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin. Infect. Dis.40, 1049–1052 (2005).
   PubMed Web of Science ®Google Scholar
• Collazos J, Mayo J, Martinez E, Blanco MS. Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS13(11), 1426 (1999).
   PubMed Web of Science ®Google Scholar
• Intalapaporn P, Poovorawan Y, Suankratay C. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy. J. Infect.1, 1–4 (2005).
   Google Scholar
• Nguyen QD, Kempen JH, Bolton SG et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am. J. Ophthalmol.129, 634–639 (2000).
   PubMed Web of Science ®Google Scholar
• Karavellas MP, Plummer DJ, Macdonald JC et al. Incidence of immune recovery vitreitis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J. Infect. Dis.179, 697–700 (1999).
   PubMed Web of Science ®Google Scholar
• Cinque P, Bossolasco S, Brambilla AM et al. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature. J. Neurovirol.9, 73–80 (2003).
   PubMed Web of Science ®Google Scholar
• Calabrese L, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin. Arthritis Rheum.35, 166–174 (2005).
   PubMed Web of Science ®Google Scholar
• Safdar A, Rubocki RJ, Horvath JA et al. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin. Infect. Dis.35, 1250–1257 (2002).
   PubMed Web of Science ®Google Scholar
• Blanche P, Gombert B, Ginsburg C et al. HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. Scand. J. Infect. Dis.30, 615–616 (1998).
   PubMed Web of Science ®Google Scholar
• Chien JW, Johnson JL. Paradoxical reaction in HIV and pulmonary TB. Chest114, 933–936 (1998).
   PubMed Web of Science ®Google Scholar
• Nuttall J, Wilmshurst J, Ndondo A et al. Progressive multifocal leukoencephalopathy after initation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr. Infect. Dis. J.23(7), 683–685 (2004).
   PubMed Web of Science ®Google Scholar
• Connick E, Kane M, White I, Ryder J, Campbell T. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin. Infect. Dis.39, 1852–1855 (2004).
   PubMed Web of Science ®Google Scholar
• Shelburne SA III, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev.5(2), 67–79 (2003).
   PubMedGoogle Scholar
• Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin. Infect. Dis.38, 1159–1166 (2004).
   PubMed Web of Science ®Google Scholar
• Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr. Opin. Infect. Dis.19, 20–25 (2006).
   PubMed Web of Science ®Google Scholar
• Elliott AM, Luzze H, Quigley MA et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J. Infect. Dis.190, 869–878 (2004).
   PubMed Web of Science ®Google Scholar
• French MA. Immune restoration disease in HIV-infected patients on HAART. AIDS Read.9, 548–562 (1999).
   PubMedGoogle Scholar
• John M, French MA. Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med. J. Aust.169, 473–474 (1998).
   PubMed Web of Science ®Google Scholar
• Crump JA, Tyrer MJ, Lloyd-Owen SJ et al. Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin. Infect. Dis.26, 1008–1009 (1998).
   PubMed Web of Science ®Google Scholar
• Hollender E, Narita M, Ashkin D et al. CNS manifestations of paradoxical reaction in HIV and TB patients on HAART. Proceedings of the Seventh Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology, 30 January–2 February, CA, USA (2000) (Abstract).
   Google Scholar
• del Giudice P, Durant J, Counillon E et al. Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch. Dermatol.135, 1129–1130 (1999).
   PubMedGoogle Scholar
• Race EM, Adelson-Mitty J, Kriegel GR et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet351, 252–255 (1998).
   PubMed Web of Science ®Google Scholar
• Schwietert M, Battegay M. [Focal mycobacterial lymphadenitis after starting highly active antiretroviral therapy]. Dtsch. Med. Wochenschr.124, 45–48 (1999).
   PubMed Web of Science ®Google Scholar
• Kaplan M. Mycobacteria avium intracellulare reversal syndrome set off by highly active antiretroviral therapy [Abstract]. Program and Abstracts of the Fifth Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, 1–5 February, IL, USA (1998).
   Google Scholar
• Cabie A, Abel S, Brebion A et al. Mycobacterial lymphadenitis after initiation of highly active antiretroviral therapy. Eur. J. Clin. Microbiol. Infect. Dis.17, 812–813 (1998).
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Fratkin MD. Mycobacterium avium complex lymph node abscess after use of highly active antiretroviral therapy in a patient with AIDS. Arch. Intern. Med.158, 1828 (1998).
   PubMed Web of Science ®Google Scholar
• Di Perri G, Bonora S, Vento S, Allegranzi B, Concia E. Highly active antiretroviral therapy. Lancet351, 1056 (1998).
   PubMedGoogle Scholar
• Foudraine NA, Hovenkamp E, Notermans DW et al. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS13, 177–184 (1999).
   PubMed Web of Science ®Google Scholar
• Sharp MJ, Mallon DF. Regional Bacillus Calmette-Guerin lymphadenitis after initiating antiretroviral therapy in an infant with human immuodeficiency virus type 1 infection. Pediatr. Infect. Dis. J.17, 660–662 (1998).
   PubMed Web of Science ®Google Scholar
• Mayanja-Kizza H, Jones-Lopez E, Okwera A et al. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. J. Infect. Dis.191, 856–865 (2005).
   PubMed Web of Science ®Google Scholar
• Karavellas MP, Lowder CY, Macdonald C, Avila CP Jr, Freeman WR. Immune recovery viritis associated inactive cytomegalovirus retinitis a new syndrome. Arch. Ophthalmol.116, 169–175 (1998).
   PubMed Web of Science ®Google Scholar
• Goldsack NR, Allen S, Lipman MC. Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy. Sex. Transm. Infect.79, 337–338 (2000).
   Google Scholar
• Fishman JE, Saraf-Lavi E, Narita M et al. Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy. Am. J. Roentgenol.174, 43–49 (1998).
   Web of Science ®Google Scholar
• Guex AC, Bucher HC, Demartines N et al. Inflammatory bowel perforation during immune restoration after one year of antiretroviral and antituberculous therapy in an HIV-1-infected patient: report of a case. Dis. Colon Rectum45, 977–978 (2002).
   PubMed Web of Science ®Google Scholar
• Jehle AW, Khanna N, Sigle JP et al. Acute renal failure upon immune reconstitution in an HIV-positive patients with miliary tuberculosis. Clin. Infect. Dis.38, e32–e35 (2004).
   PubMed Web of Science ®Google Scholar
• Legendre U, Battegay M, Nuttle I et al. Simultaneous occurrence of 2 HIV-related immune reconstitution diseases after initiation of highly active antiretroviral therapy. Scand. J. Infect. Dis.33, 388–389 (2001).
   PubMedGoogle Scholar
• Barbaro DJ, Orcutt VL, Coldiron BM. Mycobacterium avium–Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS. Rev. Infect. Dis.11, 625–628 (1989).
   PubMedGoogle Scholar
• Murry R, Mallal S, Heath C, French M. Cerebral Mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated Mycobacterium avium complex infection. Eur. J. Clin. Microbiol. Infect. Dis.20, 199–201 (2001).
   PubMed Web of Science ®Google Scholar
• Nannini EC, Okhuysen PC. HIV and the gut in the era of highly active antiretroviral therapy. Curr. Gastroenterol. Rep.4, 392–338 (2002).
   PubMedGoogle Scholar
• Woods ML, MacGinley R, Eisen DP, Allworth AM. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS12, 1491–1494 (1998).
   PubMed Web of Science ®Google Scholar
• Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin. Infect. Dis.35, e128–e133 (2002).
   PubMed Web of Science ®Google Scholar
• Trevenzoli M, Cattelan AM, Rea F et al. Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. J. Infect.45, 173–179 (2002).
   PubMed Web of Science ®Google Scholar
• Rambeloarisoa J, Batisse D, Thiebaut JB et al. Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS. J. Infect.44, 185–188 (2002).
   PubMed Web of Science ®Google Scholar
• King MD, Perlino CA, Cinnamon J, Jernigan JA. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int. J. STD AIDS13, 724–726 (2002).
   PubMed Web of Science ®Google Scholar
• Hoffman C, Horst HA, Albrecht H, Schlote W. Progressive multifocal leukoencephalopathy with unusual inflammatory response during antiretroviral treatment. J. Neurol. Neurosurg. Psychiatry74, 1142–1144 (2003).
   PubMed Web of Science ®Google Scholar
• Fox PA, Barton SE, Francis N et al. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med.1, 10–18 (1999).
   PubMedGoogle Scholar
• Domingo P, Torres OH, Ris J, Vazquez G. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am. J. Med.110, 605–609 (2001).
   PubMed Web of Science ®Google Scholar
• French M, Price P. Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy. J. HIV Ther.7, 46–51 (2002).
   PubMedGoogle Scholar
• Brown M, Williams JG, Miller RF. Deterioration of disseminated cutaneous Mycobacterium avium complex infection with a leukemoid reaction following institution for highly active antiretroviral therapy. Sex. Transm. Infect.77, 149–150 (2001).
   PubMedGoogle Scholar
• Hassell M, French MA. Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts. Eur. J. Clin. Microbiol. Infect. Dis.20, 889–891 (2001).
   PubMed Web of Science ®Google Scholar
• Kunimoto DY, Chui L, Nobert E et al. Immune mediated HAART attack during treatment for tuberculosis. Highly active antiretroviral therapy. Int. J. Tuberc. Lung Dis.3, 944–947 (1999).
   PubMed Web of Science ®Google Scholar
• Bottieau E, Noe A, Forence E et al. Development of multiple abscesses in a HIV/TB co-infected patient after initiation of antituberculous and highly active antiretroviral therapy. Acta Clin. Belg.57, 219–222 (2002).
   PubMed Web of Science ®Google Scholar
• Fernandes GC, Vieira MA, Lourenco MC et al. Inflammatory paradoxical reaction occurring in tuberculosis patients treated with HAART and rifampicin. Rev. Inst. Med. Trop. Sao Paulo44, 113–114 (2002).
   PubMedGoogle Scholar
• Ramos A, Asensio A, Perales I et al. Prolonged paradoxical reaction in tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapy. Eur. J. Clin. Microbiol. Infect. Dis.22, 374–376 (2003).
   PubMed Web of Science ®Google Scholar
• Vidal JE, Cimerman S, Schiavon NR et al. Paradoxical reaction during treatment of tuberculosis brain abscess in a patient with AIDS. Rev. Inst. Med. Trop. Sao Paulo45, 177–178 (2003).
   PubMedGoogle Scholar
• Breen RA, Smith CJ, Bettinson H et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax59, 704–707 (2004).
   PubMed Web of Science ®Google Scholar
• Sterling TR. General clinical manifestations of human immunodeficiency virus infection (including the acute retroviral syndrome and oral, cutaneous, renal, ocular, and cardiac diseases). In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds), Elsevier, Inc., PA, USA, 1546–1561 (2005).
   Google Scholar
• John M, Flexman J, French MA. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS12, 2289–2293 (1998).
   PubMed Web of Science ®Google Scholar
• Maccache JM, Antoine M, Wislez M et al. Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am. J. Respir. Crit. Care Med.159(6), 2009–2013 (1999).
   PubMed Web of Science ®Google Scholar
• Viani RM. Sarcoidosis and interstitial nephritis in a child with acquired immunodeficiency syndrome: implications of immune reconstitution syndrome with an indinavir-based regimen. Pediatr. Infect. Dis.21(5), 435–438 (2002).
   Google Scholar
• Lenner R, Bergman Z, Teirstein AS et al. Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest119(3), 978–981 (2001).
   PubMed Web of Science ®Google Scholar
• Wegrzyn J, Livrozet JM, Touraine JL et al. Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy. J. Rheumatol.29(10), 2232–2234 (2002).
   PubMed Web of Science ®Google Scholar
• Behrens G, Knuth C, Schedel I et al. Highly active antiretroviral therapy. Lancet351(9108), 1057–1058; author reply 1058–1059 (1998).
   PubMed Web of Science ®Google Scholar
• Neumann S, Kreth F, Schubert S et al. Reiter’s syndrome as a manifestation of an immune reconstitution syndrome in an HIV-infected patient: successful treatment with doxycycline. Clin. Infect. Dis.36(12), 1628–1629 (2003).
   PubMed Web of Science ®Google Scholar
• Clark B, Krueger RG, Price P, French MA. Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis. AIDS18, 1218–1221 (2004).
   PubMed Web of Science ®Google Scholar
• Bell HC, Heath CH, French MA. Pulmonary Mycobacterium celatum immune restoration disease: immunopathology and response to corticosteroid therapy. AIDS19(17), 2047–2049 (2005).
   PubMed Web of Science ®Google Scholar
• Nolan RC, Chidlow G, French MA. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection. Clin. Infect. Dis.36, 1191–1194 (2003).
   PubMed Web of Science ®Google Scholar
• Tur-Kaspa R, Burk RD, Shaul Y et al. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc. Natl Acad. Sci. USA83, 1627–1631 (1986).
   PubMed Web of Science ®Google Scholar
• Tur-Kaspa R, Shaul Y, Moore DD et al. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology167, 630–633 (1988).
   PubMed Web of Science ®Google Scholar
• Sagneilli E, Manzillo G, Maio G et al. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HbsAg-positive chronic active hepatitis. Lancet2, 395–397 (1980).
   PubMed Web of Science ®Google Scholar
• Scullard GH, Smith CI, Merigan TC et al. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology81, 987–991 (1981).
   PubMed Web of Science ®Google Scholar